FLRG (follistatin-related gene), a new target of chromosomal rearrangement in malignant blood disorders

被引:103
作者
Hayette, S
Gadoux, M
Martel, S
Bertrand, S
Tigaud, I
Magaud, JP
Rimokh, R [1 ]
机构
[1] Ctr Leon Berard, INSERM, U453, F-69373 Lyon 08, France
[2] Hop Edouard Herriot, Lab Cytogenet Mol, F-69437 Lyon, France
关键词
FLRG; follistatin; chromosomal translocation; carcinogenesis;
D O I
10.1038/sj.onc.1201807
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report here the molecular study of t(11;19)(q13;p13) translocation observed in a case of B-cell chronic lymphocytic leukemia. This translocation leads to the juxtaposition of the CCND1 gene on chromosome 11 to a new transcriptionnal unit on chromosome 19. The cDNA of this new evolutionarily conserved gene (named FLRG for Follistatin-Related Gene) codes for a secreted glycoprotein of the follistatin-module-protein family. FLRG is expressed in a wide range of human and murine adult tissues and its expression seems to be tightly regulated during murine embryogenesis. Its transcripts could not be detected in hematopoietic cells from all lineages and in particular in cells from lymphoid B and T lineage except in the t(11;19)-carrying leukemia described here. A great variability of expression is observed among the other tumoral cell lines analysed. Besides the t(11;19)-carrying leukemia described in this work, structural rearrangements of the FLRG locus have been found in a non-Hodgkin lymphoma, suggesting that it may play a role in leukemogenesis.
引用
收藏
页码:2949 / 2954
页数:6
相关论文
共 23 条
[1]   Gonadotropin-releasing hormone regulates follicle-stimulating hormone-beta gene expression through an activin/follistatin autocrine or paracrine loop [J].
Besecke, LM ;
Guendner, MJ ;
Schneyer, AL ;
BauerDantoin, AC ;
Jameson, JL ;
Weiss, J .
ENDOCRINOLOGY, 1996, 137 (09) :3667-3673
[2]  
Graham A, 1996, DEVELOPMENT, V122, P473
[3]   FOLLISTATIN, AN ANTAGONIST OF ACTIVIN, IS EXPRESSED IN THE SPEMANN ORGANIZER AND DISPLAYS DIRECT NEURALIZING ACTIVITY [J].
HEMMATIBRIVANLOU, A ;
KELLY, OG ;
MELTON, DA .
CELL, 1994, 77 (02) :283-295
[4]   DOWN-MODULATION OF C-KIT MESSENGER-RNA AND PROTEIN EXPRESSION BY ERYTHROID-DIFFERENTIATION FACTOR/ACTIVIN-A [J].
HINO, M ;
NISHIZAWA, Y ;
TATSUMI, N ;
TOJO, A ;
MORII, H .
FEBS LETTERS, 1995, 374 (01) :69-71
[5]   STRUCTURAL DOMAINS OF AGRIN REQUIRED FOR CLUSTERING OF NICOTINIC ACETYLCHOLINE-RECEPTORS [J].
HOCH, W ;
CAMPANELLI, JT ;
HARRISON, S ;
SCHELLER, RH .
EMBO JOURNAL, 1994, 13 (12) :2814-2821
[7]   THE BIOLOGY OF SPARC, A PROTEIN THAT MODULATES CELL-MATRIX INTERACTIONS [J].
LANE, TF ;
SAGE, EH .
FASEB JOURNAL, 1994, 8 (02) :163-173
[8]   ACTIVIN RECEPTORS AND CELLULAR SIGNALING BY THE RECEPTOR SERINE KINASE FAMILY [J].
MATHEWS, LS .
ENDOCRINE REVIEWS, 1994, 15 (03) :310-325
[9]   MULTIPLE DEFECTS AND PERINATAL DEATH IN MICE DEFICIENT IN FOLLISTATIN [J].
MATZUK, MM ;
LU, NF ;
VOGEL, H ;
SELLHEYER, K ;
ROOP, DR ;
BRADLEY, A .
NATURE, 1995, 374 (6520) :360-363
[10]  
Mendis DB, 1996, BRAIN RES, V730, P95